1517 |
Optimal Regiment or Duration of Anti-platelet Therapy: Dual vs Triple, 6 vs 12 Months |
Hyo-Soo Kim |
May. 12. 11 |
1516 |
Pharmacogenetic Debates in Antiplatelet Therapy |
Guillaume Pare |
May. 12. 11 |
1515 |
[Thrombus Aspiration before PCI] Selective Optional |
Myung-Ho Jeong |
May. 12. 11 |
1514 |
[Thrombus Aspiration before PCI] Routine Mandatory |
Robbert De Winter |
May. 12. 11 |
1513 |
[PCI after Successful Fibrinolysis] Selective Delayed |
Stephen G. Ellis |
May. 12. 11 |
1512 |
[PCI after Successful Fibrinolysis] Routine Early |
Mun Kyung Hong |
May. 12. 11 |
1511 |
Would More Augmentation Be Beneficial? |
Axel Neitzert |
May. 12. 11 |
1510 |
Does the Timing of IABP Matter? |
Jung-Min Ahn |
May. 12. 11 |
1509 |
Guideline Compliance, Utilization, Trends and Device Selection |
Tilmann Schwab |
May. 12. 11 |
1508 |
Why Should I Consider Two Different Approaches to tAVR |
Augusto D. Pichard |
May. 12. 11 |